- Home
- NPWR vs EXAI Comparison
NPWR vs EXAI Comparison
Compare NPWR & EXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPWR
- EXAI
- Stock Information
- Founded
- NPWR 2010
- EXAI 2012
- Country
- NPWR United States
- EXAI United Kingdom
- Employees
- NPWR N/A
- EXAI 483
- Industry
- NPWR Industrial Machinery/Components
- EXAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NPWR Energy
- EXAI Health Care
- Exchange
- NPWR Nasdaq
- EXAI Nasdaq
- Market Cap
- NPWR 665.3M
- EXAI 613.6M
- IPO Year
- NPWR N/A
- EXAI 2021
- Fundamental
- Price
- NPWR $12.67
- EXAI $4.69
- Analyst Decision
- NPWR Hold
- EXAI Hold
- Analyst Count
- NPWR 2
- EXAI 4
- Target Price
- NPWR $9.50
- EXAI $7.00
- AVG Volume (30 Days)
- NPWR 754.9K
- EXAI 702.2K
- Earning Date
- NPWR 11-11-2024
- EXAI 11-26-2024
- Dividend Yield
- NPWR N/A
- EXAI N/A
- EPS Growth
- NPWR N/A
- EXAI N/A
- EPS
- NPWR 0.11
- EXAI N/A
- Revenue
- NPWR $250,000.00
- EXAI $22,877,630.00
- Revenue This Year
- NPWR N/A
- EXAI $156.33
- Revenue Next Year
- NPWR $7,463.34
- EXAI N/A
- P/E Ratio
- NPWR $119.91
- EXAI N/A
- Revenue Growth
- NPWR 38.12
- EXAI N/A
- 52 Week Low
- NPWR $6.57
- EXAI $3.80
- 52 Week High
- NPWR $14.28
- EXAI $7.91
- Technical
- Relative Strength Index (RSI)
- NPWR 75.83
- EXAI 40.59
- Support Level
- NPWR $8.63
- EXAI $4.80
- Resistance Level
- NPWR $14.28
- EXAI $6.15
- Average True Range (ATR)
- NPWR 0.92
- EXAI 0.38
- MACD
- NPWR 0.40
- EXAI -0.01
- Stochastic Oscillator
- NPWR 72.60
- EXAI 0.00
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system which it refers to as the "NET Power Cycle is designed to produce clean, reliable and low-cost electricity from natural gas while capturing virtually all atmospheric emissions.
About EXAI Exscientia Plc
Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe, and efficacious compounds for clinical testing in humans. The company is focused on the discovery and development of small-molecule drug candidates.